GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN

A disorder of copper metabolism at Wilson’s disease (WD), conditioned by a mutation of adenosine thriphospate P-type gene (ATP7B), results in irreversible changes in the liver and in the nervous system. Mortality is high at WD, but it is one of hereditary diseases, well subjected to the therapy. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eureka, Life Sciences Life Sciences, 2020-03, Vol.2 (2), p.3-9
Hauptverfasser: Haiboniuk, Ivanna, Dats-Opoka, Marta, Makukh, Halyna, Boyko, Yaryna, Kiselyk, Igor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue 2
container_start_page 3
container_title Eureka, Life Sciences
container_volume 2
creator Haiboniuk, Ivanna
Dats-Opoka, Marta
Makukh, Halyna
Boyko, Yaryna
Kiselyk, Igor
description A disorder of copper metabolism at Wilson’s disease (WD), conditioned by a mutation of adenosine thriphospate P-type gene (ATP7B), results in irreversible changes in the liver and in the nervous system. Mortality is high at WD, but it is one of hereditary diseases, well subjected to the therapy. The disease is manifested in the early age, but its clinical course in children is symptomless that essentially complicates diagnostics. A single reliable method is genetic analysis for revealing mutations in ATP7B gene. The aim of the work was to analyze clinical manifestations and course of Wilson’s disease cases, genetically verified in children by detecting mutations of ATP7B gene. The research group included children of 6-17 years old with different injury degrees of the hepatobiliary system. According to results of the molecular-genetic analysis, the most spread allele variant of ATP7B gene (H1069Q) in Europe was confirmed in 10 patients of child age, including 4 cases of homozygosity. In 10 cases of the confirmed diagnosis of Wilson’s disease in child age in 100% (in all 10) of persons, a clinical manifestation was characterized by disorders from the hepatobiliary system, and only in 1 (10 %) – changes from the nervous system. At raising the level of transaminase in children, even at the normal bilirubin level and negative tests for viral hepatitis, it is recommended to carry out genetic testing for Wilson’s disease
doi_str_mv 10.21303/2504-5695.2020.001197
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2604173337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2604173337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1237-a6807c419acc53bd5cb547bb1680dd68fd99d99fe0cbaddc45be3db6c566767e3</originalsourceid><addsrcrecordid>eNo9kN9KwzAYxYMoOOZeQQJed-ZPk7SXpcu2YElh2fAyNEkLE7WzdRfe-Rq-3p7E1sngg3M4HM4HPwDuMZoTTBF9JAzFEeMpmxNE0BwhjFNxBSaX_PriE3ELZn2_d4ghQXGMyQQ8raSWW5XDhcpWujSDNTDTC5gXSqs8K-BSZtvdRhpYLuGzKkypT98_ZugbmRkJlYb5WhWLjdR34KapXvt69q9TsFvKbb6OinI1TkUeEyqiiidI-BinlfeMusC8Y7FwDg95CDxpQpoO19TIuyoEHzNX0-C4Z5wLLmo6BQ_n3UPXfhzr_tO-tMfufXhpCUcxFpRSMbT4ueW7tu-7urGHbv9WdV8WI_vHzo5c7MjIjuzsmR39BfRHW0k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604173337</pqid></control><display><type>article</type><title>GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Haiboniuk, Ivanna ; Dats-Opoka, Marta ; Makukh, Halyna ; Boyko, Yaryna ; Kiselyk, Igor</creator><creatorcontrib>Haiboniuk, Ivanna ; Dats-Opoka, Marta ; Makukh, Halyna ; Boyko, Yaryna ; Kiselyk, Igor</creatorcontrib><description>A disorder of copper metabolism at Wilson’s disease (WD), conditioned by a mutation of adenosine thriphospate P-type gene (ATP7B), results in irreversible changes in the liver and in the nervous system. Mortality is high at WD, but it is one of hereditary diseases, well subjected to the therapy. The disease is manifested in the early age, but its clinical course in children is symptomless that essentially complicates diagnostics. A single reliable method is genetic analysis for revealing mutations in ATP7B gene. The aim of the work was to analyze clinical manifestations and course of Wilson’s disease cases, genetically verified in children by detecting mutations of ATP7B gene. The research group included children of 6-17 years old with different injury degrees of the hepatobiliary system. According to results of the molecular-genetic analysis, the most spread allele variant of ATP7B gene (H1069Q) in Europe was confirmed in 10 patients of child age, including 4 cases of homozygosity. In 10 cases of the confirmed diagnosis of Wilson’s disease in child age in 100% (in all 10) of persons, a clinical manifestation was characterized by disorders from the hepatobiliary system, and only in 1 (10 %) – changes from the nervous system. At raising the level of transaminase in children, even at the normal bilirubin level and negative tests for viral hepatitis, it is recommended to carry out genetic testing for Wilson’s disease</description><identifier>ISSN: 2504-5687</identifier><identifier>EISSN: 2504-5695</identifier><identifier>DOI: 10.21303/2504-5695.2020.001197</identifier><language>eng</language><publisher>Tallinn: Scientific Route OÜ</publisher><subject>Adenosine ; Age ; ATP7B gene ; Bilirubin ; Children ; Disease ; Genetic analysis ; Genetic disorders ; Genetic screening ; Hepatitis ; Hereditary diseases ; Mutation ; Nervous system ; Transaminase ; Wilson's disease</subject><ispartof>Eureka, Life Sciences, 2020-03, Vol.2 (2), p.3-9</ispartof><rights>2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1237-a6807c419acc53bd5cb547bb1680dd68fd99d99fe0cbaddc45be3db6c566767e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Haiboniuk, Ivanna</creatorcontrib><creatorcontrib>Dats-Opoka, Marta</creatorcontrib><creatorcontrib>Makukh, Halyna</creatorcontrib><creatorcontrib>Boyko, Yaryna</creatorcontrib><creatorcontrib>Kiselyk, Igor</creatorcontrib><title>GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN</title><title>Eureka, Life Sciences</title><description>A disorder of copper metabolism at Wilson’s disease (WD), conditioned by a mutation of adenosine thriphospate P-type gene (ATP7B), results in irreversible changes in the liver and in the nervous system. Mortality is high at WD, but it is one of hereditary diseases, well subjected to the therapy. The disease is manifested in the early age, but its clinical course in children is symptomless that essentially complicates diagnostics. A single reliable method is genetic analysis for revealing mutations in ATP7B gene. The aim of the work was to analyze clinical manifestations and course of Wilson’s disease cases, genetically verified in children by detecting mutations of ATP7B gene. The research group included children of 6-17 years old with different injury degrees of the hepatobiliary system. According to results of the molecular-genetic analysis, the most spread allele variant of ATP7B gene (H1069Q) in Europe was confirmed in 10 patients of child age, including 4 cases of homozygosity. In 10 cases of the confirmed diagnosis of Wilson’s disease in child age in 100% (in all 10) of persons, a clinical manifestation was characterized by disorders from the hepatobiliary system, and only in 1 (10 %) – changes from the nervous system. At raising the level of transaminase in children, even at the normal bilirubin level and negative tests for viral hepatitis, it is recommended to carry out genetic testing for Wilson’s disease</description><subject>Adenosine</subject><subject>Age</subject><subject>ATP7B gene</subject><subject>Bilirubin</subject><subject>Children</subject><subject>Disease</subject><subject>Genetic analysis</subject><subject>Genetic disorders</subject><subject>Genetic screening</subject><subject>Hepatitis</subject><subject>Hereditary diseases</subject><subject>Mutation</subject><subject>Nervous system</subject><subject>Transaminase</subject><subject>Wilson's disease</subject><issn>2504-5687</issn><issn>2504-5695</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9kN9KwzAYxYMoOOZeQQJed-ZPk7SXpcu2YElh2fAyNEkLE7WzdRfe-Rq-3p7E1sngg3M4HM4HPwDuMZoTTBF9JAzFEeMpmxNE0BwhjFNxBSaX_PriE3ELZn2_d4ghQXGMyQQ8raSWW5XDhcpWujSDNTDTC5gXSqs8K-BSZtvdRhpYLuGzKkypT98_ZugbmRkJlYb5WhWLjdR34KapXvt69q9TsFvKbb6OinI1TkUeEyqiiidI-BinlfeMusC8Y7FwDg95CDxpQpoO19TIuyoEHzNX0-C4Z5wLLmo6BQ_n3UPXfhzr_tO-tMfufXhpCUcxFpRSMbT4ueW7tu-7urGHbv9WdV8WI_vHzo5c7MjIjuzsmR39BfRHW0k</recordid><startdate>20200331</startdate><enddate>20200331</enddate><creator>Haiboniuk, Ivanna</creator><creator>Dats-Opoka, Marta</creator><creator>Makukh, Halyna</creator><creator>Boyko, Yaryna</creator><creator>Kiselyk, Igor</creator><general>Scientific Route OÜ</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200331</creationdate><title>GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN</title><author>Haiboniuk, Ivanna ; Dats-Opoka, Marta ; Makukh, Halyna ; Boyko, Yaryna ; Kiselyk, Igor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1237-a6807c419acc53bd5cb547bb1680dd68fd99d99fe0cbaddc45be3db6c566767e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenosine</topic><topic>Age</topic><topic>ATP7B gene</topic><topic>Bilirubin</topic><topic>Children</topic><topic>Disease</topic><topic>Genetic analysis</topic><topic>Genetic disorders</topic><topic>Genetic screening</topic><topic>Hepatitis</topic><topic>Hereditary diseases</topic><topic>Mutation</topic><topic>Nervous system</topic><topic>Transaminase</topic><topic>Wilson's disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haiboniuk, Ivanna</creatorcontrib><creatorcontrib>Dats-Opoka, Marta</creatorcontrib><creatorcontrib>Makukh, Halyna</creatorcontrib><creatorcontrib>Boyko, Yaryna</creatorcontrib><creatorcontrib>Kiselyk, Igor</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Eureka, Life Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haiboniuk, Ivanna</au><au>Dats-Opoka, Marta</au><au>Makukh, Halyna</au><au>Boyko, Yaryna</au><au>Kiselyk, Igor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN</atitle><jtitle>Eureka, Life Sciences</jtitle><date>2020-03-31</date><risdate>2020</risdate><volume>2</volume><issue>2</issue><spage>3</spage><epage>9</epage><pages>3-9</pages><issn>2504-5687</issn><eissn>2504-5695</eissn><abstract>A disorder of copper metabolism at Wilson’s disease (WD), conditioned by a mutation of adenosine thriphospate P-type gene (ATP7B), results in irreversible changes in the liver and in the nervous system. Mortality is high at WD, but it is one of hereditary diseases, well subjected to the therapy. The disease is manifested in the early age, but its clinical course in children is symptomless that essentially complicates diagnostics. A single reliable method is genetic analysis for revealing mutations in ATP7B gene. The aim of the work was to analyze clinical manifestations and course of Wilson’s disease cases, genetically verified in children by detecting mutations of ATP7B gene. The research group included children of 6-17 years old with different injury degrees of the hepatobiliary system. According to results of the molecular-genetic analysis, the most spread allele variant of ATP7B gene (H1069Q) in Europe was confirmed in 10 patients of child age, including 4 cases of homozygosity. In 10 cases of the confirmed diagnosis of Wilson’s disease in child age in 100% (in all 10) of persons, a clinical manifestation was characterized by disorders from the hepatobiliary system, and only in 1 (10 %) – changes from the nervous system. At raising the level of transaminase in children, even at the normal bilirubin level and negative tests for viral hepatitis, it is recommended to carry out genetic testing for Wilson’s disease</abstract><cop>Tallinn</cop><pub>Scientific Route OÜ</pub><doi>10.21303/2504-5695.2020.001197</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2504-5687
ispartof Eureka, Life Sciences, 2020-03, Vol.2 (2), p.3-9
issn 2504-5687
2504-5695
language eng
recordid cdi_proquest_journals_2604173337
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adenosine
Age
ATP7B gene
Bilirubin
Children
Disease
Genetic analysis
Genetic disorders
Genetic screening
Hepatitis
Hereditary diseases
Mutation
Nervous system
Transaminase
Wilson's disease
title GENETIC DIAGNOSTICS AND CLINICAL FEATURES OF WILSON’S DISEASE IN CHILDREN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A47%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GENETIC%20DIAGNOSTICS%20AND%20CLINICAL%20FEATURES%20OF%20WILSON%E2%80%99S%20DISEASE%20IN%20CHILDREN&rft.jtitle=Eureka,%20Life%20Sciences&rft.au=Haiboniuk,%20Ivanna&rft.date=2020-03-31&rft.volume=2&rft.issue=2&rft.spage=3&rft.epage=9&rft.pages=3-9&rft.issn=2504-5687&rft.eissn=2504-5695&rft_id=info:doi/10.21303/2504-5695.2020.001197&rft_dat=%3Cproquest_cross%3E2604173337%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604173337&rft_id=info:pmid/&rfr_iscdi=true